These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 7146822
1. Lymphopenia: a bad prognostic factor in Hodgkin's disease. Hancock BW, Dunsmore IR, Swan HT. Scand J Haematol; 1982 Sep; 29(3):193-9. PubMed ID: 7146822 [Abstract] [Full Text] [Related]
2. The pretreatment peripheral blood lymphocyte count in 1100 patients with Hodgkin's disease: the prognostic significance and the relationship to the presence of systemic symptoms. MacLennan KA, Hudson BV, Jelliffe AM, Haybittle JL, Hudson GV. Clin Oncol; 1981 Dec; 7(4):333-9. PubMed ID: 7318276 [No Abstract] [Full Text] [Related]
3. Immune status of untreated patients with Hodgkin's disease and prognosis. Björkholm M, Wedelin C, Holm G, Ogenstad S, Johansson B, Mellstedt H. Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640 [Abstract] [Full Text] [Related]
4. Interrelationship between several prognostic factors in Hodgkin's disease. Kotlarek-Haus S, Gabryś K, Starzyk H, Sciborski R, Gałazka Z. Arch Geschwulstforsch; 1982 Apr; 52(4):293-301. PubMed ID: 7138241 [Abstract] [Full Text] [Related]
5. Hodgkin's and non-Hodgkin's lymphoma of the head and neck. Urquhart A, Berg R. Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605 [Abstract] [Full Text] [Related]
10. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Mauch PM, Kalish LA, Marcus KC, Shulman LN, Krill E, Tarbell NJ, Silver B, Weinstein H, Come S, Canellos GP, Coleman CN. Cancer J Sci Am; 1995 Sep; 1(1):33-42. PubMed ID: 9166452 [Abstract] [Full Text] [Related]
11. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials. Shimabukuro-Vornhagen A, Haverkamp H, Engert A, Balleisen L, Majunke P, Heil G, Eich HT, Stein H, Diehl V, Josting A. J Clin Oncol; 2005 Aug 20; 23(24):5739-45. PubMed ID: 16009944 [Abstract] [Full Text] [Related]
12. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. Smith RS, Chen Q, Hudson MM, Link MP, Kun L, Weinstein H, Billett A, Marcus KJ, Tarbell NJ, Donaldson SS. J Clin Oncol; 2003 May 15; 21(10):2026-33. PubMed ID: 12743158 [Abstract] [Full Text] [Related]
16. Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group. Nogová L, Reineke T, Brillant C, Sieniawski M, Rüdiger T, Josting A, Bredenfeld H, Skripnitchenko R, Müller RP, Müller-Hermelink HK, Diehl V, Engert A, German Hodgkin Study Group. J Clin Oncol; 2008 Jan 20; 26(3):434-9. PubMed ID: 18086799 [Abstract] [Full Text] [Related]
20. [Immunological data in the clinical evaluation of Hodgkin's diseases]. Burchardt K. Z Gesamte Inn Med; 1981 Nov 01; 36(21):840. PubMed ID: 6977241 [Abstract] [Full Text] [Related] Page: [Next] [New Search]